中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
34期
71-71,73
,共2页
剖宫产%中期妊娠%引产%米非司酮%利凡诺
剖宮產%中期妊娠%引產%米非司酮%利凡諾
부궁산%중기임신%인산%미비사동%리범낙
Cesarean section%Mid pregnancy%Induction of labor%Mifepristone%Rivanol
目的：探讨一种对于剖宫产术后中期引产相对安全有效的方法。方法：2010-2012年收治1次剖宫产术后中期妊娠引产患者80例，随机分为两组。治疗组40例，给予利凡诺联合米非司酮引产；对照组40例，给予利凡诺引产。观察引产效果及并发症。结果：治疗组引产时间、产后出血量及胎膜残留率与对照组差异有统计学意义(P＜0.05)。结论：利凡诺结合米非司酮对于剖宫产术后中期引产的治疗相对安全、有效、并发症少，值得临床推广。
目的：探討一種對于剖宮產術後中期引產相對安全有效的方法。方法：2010-2012年收治1次剖宮產術後中期妊娠引產患者80例，隨機分為兩組。治療組40例，給予利凡諾聯閤米非司酮引產；對照組40例，給予利凡諾引產。觀察引產效果及併髮癥。結果：治療組引產時間、產後齣血量及胎膜殘留率與對照組差異有統計學意義(P＜0.05)。結論：利凡諾結閤米非司酮對于剖宮產術後中期引產的治療相對安全、有效、併髮癥少，值得臨床推廣。
목적：탐토일충대우부궁산술후중기인산상대안전유효적방법。방법：2010-2012년수치1차부궁산술후중기임신인산환자80례，수궤분위량조。치료조40례，급여리범낙연합미비사동인산；대조조40례，급여리범낙인산。관찰인산효과급병발증。결과：치료조인산시간、산후출혈량급태막잔류솔여대조조차이유통계학의의(P＜0.05)。결론：리범낙결합미비사동대우부궁산술후중기인산적치료상대안전、유효、병발증소，치득림상추엄。
Objective:To explore a relatively safe and effective method of middle pregnancy induced labor after cesarean section. Methods:80 cases of middle pregnancy induced labor for mid-term after cesarean section were selected from 2010 to 2012.They were randomly divided into the treatment group and the control group with 40 cases in each.Patients in the treatment group were induced labor with rivanol and mifepristone.Patients in the control group were only given rivanol.Then we observed the effect and complications of abortion.Results:There were significantly different in labor time,postpartum hemorrhage and fetal membranes residue rate between the treatment group and the control group(P<0.05).Conclusion:Rivanol combined with mifepristone in the treatment of middle pregnancy induced labor after cesarean section is relatively safe and effective,in addation,it also had less complication,so it is worthy of clinical promotion.
